Release Summary

Blaze Bioscience announces open enrollment for Phase 1 clinical trial of Tumor Paint BLZ-100 in children with brain cancer. This is the second BLZ-100 clinical study under the company's open U.S. IND.

Blaze Bioscience, Inc.